18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor–Related “Retroperitoneal Panniculitis”
Authors:
- Silvana ParisiSPSilvana Parisi
- Riccardo LaudicellaRLRiccardo Laudicella
- Stefano PergolizziSPStefano Pergolizzi
- Sergio BaldariSBSergio Baldari
- 15 July 2021
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 47 (1) , e39-e40
Abstract
A 71-year-old woman was operated on for undifferentiated lung adenocarcinoma. Four months after surgery, she developed bone and adrenal metastases. She underwent palliative radiation therapy of left scapula and right iliac bone. Thereafter, she started immune checkpoint inhibitor (ICI) therapy with anti–PD-1 antibodies achieving complete tumor response. Twenty months later, a follow-up 18F-FDG PET/CT confirmed tumor response and revealed high radiotracer accumulation in correspondence of retroperitoneal and subcutaneous fat opacities. The contiguous fasciae were mildly thickened. The temporal relation with ICI therapy together with tumor response and corticosteroids therapy effectiveness led to conclude for ICI-related adverse events.Keywords
This publication has 12 references indexed in Scilit:
- Nivolumab-Induced Subcutaneous Fat NecrosisClinical Nuclear Medicine, 2019
- Rapidly Evolving Extensive Fluorodeoxyglucose-Positive Soft-Tissue Activity During Nivolumab TherapyJAMA Oncology, 2019
- Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective StudyJournal of Clinical Medicine Research, 2019
- Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case seriesEuropean Journal of Cancer, 2018
- Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitorsAutoimmunity Reviews, 2018
- Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapyJAAD Case Reports, 2018
- Combination of immune checkpoint inhibitors and radiotherapy: Review of the literatureCritical Reviews in Oncology/Hematology, 2017
- Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancerExpert Opinion on Drug Safety, 2017
- Radioanatomy of the retroperitoneal spaceDiagnostic and Interventional Imaging, 2015
- Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti–CTLA-4 Antibody TherapyAmerican Journal of Roentgenology, 2011